skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts

Review

(1986) Views  (642) Full article downloads

Authors: Johanna M Porter-Kelley, Joann Cofie, Sophonie Jean, et al

Published Date August 2010 Volume 2010:3 Pages 87 - 94
DOI: http://dx.doi.org/10.2147/IDR.S7454

Johanna M Porter-Kelley1, Joann Cofie2, Sophonie Jean2, Mark E Brooks1, Mia Lassiter1, DC Ghislaine Mayer2

1Life Sciences Department, ­Winston-Salem State University, Winston Salem, NC, USA; 2Department of Biology, Virginia Commonwealth University, Richmond, VA, USA

Abstract: Malaria, a disease of poverty and high morbidity and mortality in the tropical world, has led to a worldwide search for control measures. To that end, good antimalarial chemotherapies have been difficult to find in the global market and those that seem to be most effective are rapidly becoming ineffective due to the emergence and spread of drug resistance. Artemisinin, a very effective yet expensive antimalarial, has quickly become the recommended drug of choice when all other possibilities fail. However, for all its promise as the next great antimalarial, the outlook is bleak. Resistance is developing to artemisinin while another effective antimalarial is not in sight. Malaria endemic areas which are mostly in developing countries must deal with the multifaceted process of changing and implementing new national malaria treatment guidelines. This requires complex interactions between several sectors of the affected society which in some cases take place within the context of political instability. Moreover, the cost associated with preventing and containing the spread of antimalarial resistance is detrimental to economic progress. This review addresses the impact of artemisinin resistance on the socioeconomic structure of malaria endemic countries.

Keywords: artemisinin-based drugs, social, economic, malarial parasite resistance







Readers of this article also read:

Emerging agents to combat complicated and resistant infections: focus on ceftobiprole
Prevention strategies for antimicrobial resistance: a systematic review of the literature
Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
International advocacy against DDT and other public health insecticides for malaria control
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Identification of Hepatocystis species in a macaque monkey in northern Myanmar
Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire
Implications of public-health insecticide resistance and replacement costs for malaria control: challenges and policy options for endemic countries and donors
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University